New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies
The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours
Ghrelin, not just another growth hormone secretagogue
Corticotrophin-releasing hormone and parturition
Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to Type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies
Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects
Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour?
Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents‡
Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion tests
Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults
Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals
The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males
Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men
Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect
A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function
Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes
Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1
Comments on ‘Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study’ by Florakis et al. (2000)
Comments on ‘Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study’ by Florakis
Choice of hormone replacement therapy in young women with ovarian failure
Choice of hormone replacement therapy in young women with ovarian failure
Errata